Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Richard Charles Mohs
Agenebio, Inc., Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Cogstate, Ltd.
Equity Interest - Publicly traded entity (e.g., stock, stock option, or other ownership interest)
Cogstate, Ltd. is an AgeneBio vendor that provides rater-training and scale quality oversight services for the grant-funded clinical trial.
A Phase 3 Pivotal Trial of AGB101 to Slow Progression in MCI due to Alzheimer's Disease
This clinical study tests a novel approach to Alzheimer?s disease in patients at high risk for dementia and, as such, would address a critical unmet need that will otherwise significantly burden patients, caregivers and the healthcare system in the decades ahead. Using AGB101, a low dose, once-a-day medication of levetiracetam, a drug with proven safety and tolerability at much higher doses for use in treating epilepsy, this Phase 3 trial assesses the efficacy of a 78-week therapy in slowing the progression of amnestic mild cognitive impairment due to AD. The study uses endpoints consistent with regulatory guidance for this indication and will produce publically available data that can be used to advance AD dementia prevention trial design and biomarker development.
Filed on May 16, 2019.
Tell us what you know about Richard Charles Mohs's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Richard Charles Mohs filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Richard Charles Mohs | Agenebio, Inc. | Conflict of Interest | Cogstate, Ltd. | $20,000 - $39,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.